Becker's Healthcare June 6, 2019
Andrea Park

The American Medical Informatics Association submitted a letter to the FDA this week not only praising the agency’s proposed regulatory framework concerning the use of self-updating artificial intelligence in medicine, but also encouraging even stricter regulations.

In April, the FDA issued a discussion paper and request for feedback regarding this proposed framework, which would regulate the use of medical device algorithms that use machine learning to continually update as they are fed more data. Currently, the FDA only authorizes the use of AI products that...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Regulations, Technology
Understanding the Value of the Home as a Healthcare Site
FDA approves Lumicell’s breast cancer imaging tool
Boehringer Ingelheim Strikes Regenerative Med R&D Deal Spanning MASH & More Liver Diseases
Opinion: An FDA pathway can accelerate innovation for Duchenne muscular dystrophy
What principles should guide artificial intelligence innovation in healthcare?

Share This Article